Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ELVN | US
2.23
8.81%
Healthcare
Biotechnology
30/06/2024
04/10/2024
27.53
26.12
27.62
25.48
Enliven Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001 which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002 a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder Colorado.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.1%1 month
53.3%3 months
56.6%6 months
71.7%-
-
3.74
0.00
0.00
-6.28
-
-
-95.95M
1.30B
1.30B
-
-
-
-
-28.37
41.69
28.98
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
5.23
Range1M
6.25
Range3M
6.85
Rel. volume
1.16
Price X volume
9.72M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
NRIX | NRIX | Biotechnology | 22.2 | 1.43B | 1.05% | n/a | 7.77% |
Longboard Pharmaceuticals Inc. Common Stock | LBPH | Biotechnology | 36.22 | 1.41B | -0.55% | n/a | 1.31% |
Xencor Inc | XNCR | Biotechnology | 19.85 | 1.39B | 2.00% | n/a | 15.54% |
Day One Biopharmaceuticals Inc. Common Stock | DAWN | Biotechnology | 14.1 | 1.39B | 3.52% | n/a | 0.06% |
Kura Oncology Inc | KURA | Biotechnology | 18.04 | 1.38B | -2.49% | n/a | 3.59% |
SPRY | SPRY | Biotechnology | 14.19 | 1.38B | -1.80% | n/a | 0.07% |
Tarsus Pharmaceuticals Inc | TARS | Biotechnology | 33.89 | 1.31B | 3.48% | n/a | 28.62% |
Avadel Pharmaceuticals plc | AVDL | Biotechnology | 13.09 | 1.26B | 0.23% | n/a | 53.59% |
Mesoblast Limited | MESO | Biotechnology | 10.81 | 1.26B | 23.40% | n/a | 24.76% |
Wave Life Sciences Ltd | WVE | Biotechnology | 8.41 | 1.24B | -4.76% | n/a | 656.70% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Janus International Group Inc. | JBI | Building Products & Equipment | 9.79 | 1.42B | 2.73% | 11.54 | 116.21% |
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
Camping World Holdings Inc | CWH | Recreational Vehicles | 23.44 | 1.06B | -0.38% | n/a | 3644.76% |
Malibu Boats Inc | MBUU | Recreational Vehicles | 39.7 | 793.63M | -0.68% | n/a | 1.50% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -6.28 | 0.76 | Cheaper |
Ent. to Revenue | - | 3,674.48 | - |
PE Ratio | - | 38.01 | - |
Price to Book | 3.74 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 56.65 | 74.67 | Lower Risk |
Debt to Equity | 0.00 | -1.82 | Expensive |
Debt to Assets | 0.00 | 0.26 | Cheaper |
Market Cap | 1.30B | 3.73B | Emerging |